VL
XBI icon

Vima LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Vima LLC’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.3K Buy
+343
New +$46.4K 0.05% 150
2024
Q2 		– Sell
-500
Closed -$38.1K – 390
2024
Q1 		$38.1K Hold
500
– – 0.04% 130
2023
Q4 		$44.6K Buy
+500
New +$37.1K 0.1% 128

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

Vima LLC's XBI Position: Q2 2026 in Review

Vima LLC opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 343 shares worth $54.3K. The stake represents 0.05% of the portfolio and ranks #150 among its holdings. This is a return to the name: Vima LLC previously reported a position in XBI as recently as Q1 2024.

Vima LLC first reported a position in XBI in Q4 2023 and has held it in 3 quarters since. 416 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Vima LLC held 343 shares of State Street SPDR S&P Biotech ETF worth $54.3K as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Vima LLC position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Vima LLC's portfolio in Q2 2026, its #150 holding.
  • Vima LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 3 quarters since.
  • 416 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Vima LLC's 13F filing for Q2 2026, filed 24 Jul 2026.